BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7468695)

  • 21. Assessment of reliability endometrial brush cytology in detection etiology of late postmenopausal bleedings.
    Milojkovic M; Hrgovic Z; Maass N; Jonat W; Hrgovic I; Buković D; Sijanovic S
    Arch Gynecol Obstet; 2004 May; 269(4):259-62. PubMed ID: 15221320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compliance with referrals from a cancer-screening project.
    Lane DS
    J Fam Pract; 1983 Nov; 17(5):811-7. PubMed ID: 6631345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An old problem of current gynecology: endometrial carcinoma. Preventive aspects].
    Ferraris G
    Minerva Med; 1977 Feb; 68(4):227-8. PubMed ID: 840418
    [No Abstract]   [Full Text] [Related]  

  • 24. Endocyte endometrial smears in the cytodiagnosis of endometrial carcinoma.
    Byrne AJ
    Acta Cytol; 1990; 34(3):373-81. PubMed ID: 2343695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
    Persson I; Adami HO; Bergkvist L; Lindgren A; Pettersson B; Hoover R; Schairer C
    BMJ; 1989 Jan; 298(6667):147-51. PubMed ID: 2538173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for endometrial adenocarcinoma.
    Colacurci N; De Placido G; Mercorio F; Zullo F; D'Agostino G; Montemagno U
    Eur J Gynaecol Oncol; 1988; 9(1):62-6. PubMed ID: 3278911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress report on experimental use of CYBEST model 2 for practical gynecologic mass screening. Alterations of the specimen rejection threshold and specimen preparation.
    Mukawa A; Kamitsuma Y; Jisaki F; Tanaka N; Ikeda H; Ueno T; Tsunekawa S
    Anal Quant Cytol; 1983 Mar; 5(1):31-4. PubMed ID: 6846967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic reliability of Mi-Mark helix technique in endometrial neoplasia.
    Ginsberg NA; Padleckas R; Javaheri G
    Obstet Gynecol; 1983 Aug; 62(2):225-30. PubMed ID: 6866365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of endometrial sampling compared to conventional dilatation and curettage in women with abnormal uterine bleeding.
    Abdelazim IA; Abdelrazak KM; Elbiaa AA; Al-Kadi M; Yehia AH
    Arch Gynecol Obstet; 2015 May; 291(5):1121-6. PubMed ID: 25367600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening for endometrial carcinoma in a group at risk].
    Morack G; Ebeling K; Flach W; Peschel HG; Pockrandt H
    Arch Geschwulstforsch; 1984; 54(5):415-22. PubMed ID: 6497587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Status of fractionated abrasion and vaginal endocervical cytology in diagnosis of endometrial cancer].
    Schild R; Kutta T
    Geburtshilfe Frauenheilkd; 1992 Aug; 52(8):467-70. PubMed ID: 1397942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system.
    Thrall M; Kjeldahl K; Gulbahce HE; Pambuccian SE
    Cancer; 2007 Aug; 111(4):217-23. PubMed ID: 17599738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis by endometrial jet washings.
    Hibbard LT; Schwinn CE
    Am J Obstet Gynecol; 1971 Dec; 111(8):1039-42. PubMed ID: 4331614
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic value of micro-histology in endometrial brushing.
    Manini C; Montironi PL; Magistris A; Stramignoni D
    Pathologica; 2010 Apr; 102(2):46-50. PubMed ID: 23596756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [What can be expected from vaginal smears every three years in the secondary prevention of uterine cancer?].
    Dargent D; Chomier M
    Presse Med; 1992 Mar; 21(9):438. PubMed ID: 1533039
    [No Abstract]   [Full Text] [Related]  

  • 36. Value of cytology for detecting endometrial abnormalities in climacteric women receiving hormone replacement therapy.
    Studd JW; Thom M; Dische F; Driver M; Evans TW; Williams D
    Br Med J; 1979 Mar; 1(6167):846-8. PubMed ID: 435840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytohormonal and cancer screening procedure for endometrial carcinoma.
    Nagy P; Keller G; Csaba IF
    Zentralbl Gynakol; 1985; 107(3):169-74. PubMed ID: 3984571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of endometrial aspiration cytology in assessing endometrial status in symptomatic peri and postmenopausal women.
    Liza Sister ; Rameshkumar K; Lillian Sister
    Indian J Cancer; 1999 Mar; 36(1):57-61. PubMed ID: 10810556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity and specificity of endocervical curettage and the endocervical brush for the evaluation of the endocervical canal.
    Andersen W; Frierson H; Barber S; Tabbarah S; Taylor P; Underwood P
    Am J Obstet Gynecol; 1988 Sep; 159(3):702-7. PubMed ID: 3048105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.